Abstract

Abstract Liver cirrhosis is associated with a 70% decrease of peripheral CD27+ memory B cells. The mechanism for CD27+ B-cell loss in cirrhosis remains unknown. We hypothesize that increased sensitivity to fas-mediated apoptosis leads to reduced peripheral CD27+ B-cells survival. Methods: Ex vivo B-cell fas-receptor (CD95) expression and in vitro measurement of spontaneous and fas-induced apoptosis (annexin V/PI) in 11 cirrhotic (CIR) and 11 healthy donors (HD). We found that expression of CD95 was significantly higher in CD27+ B cells than in CD27- B-cells in both CIR and HD (CIR, 50.2% versus 3.8%, p< 0.0001). The ex vivo percentage and gMFI of CD95 on CD27+ B-cells was significantly higher in CIR than HD (CIR 50.2% versus HD 34.6%; CIR 624 versus HD 337, p<0.02). Surprisingly, ex vivo CD27+ B cells were resistant to fas-mediated apoptosis in both CIR and HD. Anti-CD40 activation of sort-purified CD27+ and CD27- B cells resulted in upregulation of CD95 (1.05-1.17-log-fold) to similar degrees in CIR and HD. Addition of agonist anti-fas resulted in significantly greater apoptosis in cirrhotic CD27+ B cells relative to HD (CIR 33.3% versus HD 18.5%, p=0.05). Conclusion: These data suggest that peripheral CD27+ memory B-cell in cirrhosis exhibit increased sensitivity to fas-induced apoptosis in an activation-dependent manner. This sensitivity may be associated with their reduced frequency in cirrhosis and possibly with resultant derangements of humoral immunity seen in cirrhosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call